@zimbuckapp: 🚨 BREAKING: GeneDx plunges 16.6% after cutting its growth target GeneDx (WGS) shares fell 16.6% to $54.83 on Tuesday after the genetic testing company lowered its growth outlook. Q3 sales rose 5% to $123.1M, in line with estimates, and EPS of $0.28 beat forecasts — but testing volume rose 25% to 32,134 results, short of the 29.2%+ growth promised. Management kept its revenue forecast but cut its full-year volume growth target to a minimum of 28%. #GeneDx #WGS #Stocks #Earnings #Biotech #StockMarket #Investing Join the conversation on Zimbuck — the finance social platform for traders & investors: https://zimbuck.com

Zimbuck App

Open In TikTok:

Region: ES

Wednesday 11 November 2026 03:10:06 GMT